small molecule

EXXUA

GEPIRONE HYDROCHLORIDE

Loss of exclusivitySeptember 2030latest FDA-listed patent expiry

CompanyFABRE KRAMER PHARMACEUTICALS INC

Drug detail

Brand name	EXXUA
Active ingredient	GEPIRONE HYDROCHLORIDE
Strength	EQ 18.2MG BASE
Dosage form	TABLET, EXTENDED RELEASE
Route	ORAL
Modality	Small molecule
FDA approval	September 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
7538116	September 2030	use U-3699

Regulatory exclusivity

Code	Expires
NCE	September 2028

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from FABRE KRAMER PHARMACEUTICALS INC